Lorlatinib for advanced anaplastic lymphoma kinase–positive non–small cell lung cancer: Results of the IFCT-1803 LORLATU cohort

Etude concernée: IFCT-1803
Auteurs / Authors: Baldacci S, Besse B, Avrillon V, Mennecier B, Mazieres J, Dubray-Longeras P, Cortot AB, Descourt R, Doubre H, Quantin X, Duruisseaux M, Monnet I, Moro-Sibilot D, Cadranel J, Clément-Duchêne C, Cousin S, Ricordel C, Merle P, Otto J, Schneider S, Langlais A, Morin F, Westeel V, Girard N.
Journal / Conference: European Journal of Cancer
Année / Year: 2022
PMID: 35278825
Lien vers la publication: https://www.sciencedirect.com/science/article/pii/S0959804922000417?dgcid=coauthor
PDF: LORLATU.EJC.042022.pdf